• Transactions
  • Careers
  • Contact
  • Client Login
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

Leerink Partners

Helping our clients move healthcare forward

  • Sectors
    • Biopharma
    • Digital Health & HealthTech
    • Healthcare Services
    • Medical Technology
    • Tools & Diagnostics
  • Solutions
    • For Corporates
      • M&A Advisory
      • Capital Markets
      • Leveraged and Private Capital Markets
    • For Investors
      • Equity Research
      • Institutional Equities
      • Corporate Access
  • Intelligence
    • Perspectives
    • MEDACorp
  • Firm
    • About
    • Careers
    • News
    • Transactions
Jed Brody

Jed Brody

Senior Managing Director, Healthcare Mergers & Acquisitions

Jed Brody is a Senior Managing Director of Healthcare Investment Banking at Leerink Partners. With over 20 years of experience, he will lead the firm’s M&A advisory business across major sectors of healthcare, including healthcare-focused private equity.

Jed joined the firm in 2021 from Barclays where he most recently was Co-Head of Healthcare Americas and Global Head of Healthcare M&A. While at Barclays, he worked on many transactions including, but not limited to, CVS Health’s $69 billion acquisition of Aetna, ICU Medical’s $2.35 billion acquisition of Smiths Medical, the sale of Equian to UnitedHealth Group for $2.35 billion, the sale of Kindred Healthcare to Lifepoint, Sun Life’s $2.5 billion acquisition of DentaQuest, Centene’s $17.3 billion acquisition of WellCare. Prior to this, he was at Lehman Brothers.

He earned his BS in Finance from Lehigh University.

Partner with Us

to achieve your strategic, capital markets, and investment objectives.

Contact Us

Footer

Sectors

  • Biopharma
  • Digital Health & HealthTech
  • Healthcare Services
  • Medical Technology
  • Tools & Diagnostics

Solutions

  • For Corporates
  • For Investors
  • Transactions
  • Advisory

Intelligence

  • Perspectives
  • Research
  • MEDACorp

Firm

  • About
  • Careers
  • News

Contact

  • General
  • Investors
  • Press

Stay ahead of what’s next. Sign Up Now!

Subscribe to receive our thought leadership and marketing updates.

This field is for validation purposes and should be left unchanged.

Member  FINRA/SIPC

  • Terms of Use
  • Privacy
  • Cookies
  • Notice to California Residents
  • Important Disclosures
  • Linkedin
  • Mail

Contact Us

Thank you for visiting Leerink.com. If you would like more information, please submit an inquiry below.

"*" indicates required fields

Name*